Sector: Biological Products, (No Diagnostic Substances)Industry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 32 of Protalix BioTherapeutics, Inc.'s SEC filings and found 1 warrant series, 1 convertible, 2 ATM programs and 2 shelf registrations on file for PLX. The latest dilution event on file is ATM sales on Jun 30, 2026. Analysis updated Nov 1, 2026.
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z
ARTVArtiva Biotherapeutics, Inc.
ACIUAC Immune SA
PALIPalisade Bio, Inc.
IKTInhibikase Therapeutics, Inc.
ADCTADC Therapeutics SA
AKBAAkebia Therapeutics, Inc.
ELDNEledon Pharmaceuticals, Inc.
DTILPrecision BioSciences, Inc.
SLGLSol-Gel Technologies Ltd. Ordinary Shares
RNACCartesian Therapeutics, Inc.
PYXSPyxis Oncology, Inc.
CGENCompugen Ltd
INOInovio Pharmaceuticals, Inc.
KRROKorro Bio, Inc.
PRQRProQR Therapeutics N.V. Ordinary Shares